Gsa Capital Partners LLP Mirati Therapeutics, Inc. Transaction History

Gsa Capital Partners LLP

  • $1.19 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$132.13 - $177.45 $275,226 - $369,628
-2,083 Closed
0 $0
Q2 2021

Aug 05, 2021
BUY
$144.0 - $179.73 $299,952 - $374,377
2,083 New
2,083 $336,000
Q2 2018

Aug 09, 2018
SELL
$26.05 - $52.4 $430,971 - $866,905
-16,544 Closed
0 $0
Q1 2018

May 11, 2018
BUY
$17.2 - $34.95 $284,556 - $578,212
16,544 New
16,544 $508,000

Others Institutions Holding MRTX

# of Institutions
19
Shares Held
3.57M
Call Options Held
0
Put Options Held
36.6K
View Full List

About Mirati Therapeutics, Inc.

MRTX Quotes by TradingView
  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email